Eli Lilly Commits $3.5 Billion to Pennsylvania Obesity Drug Plant, Creating 850 Jobs in Largest Life Sciences Investment in State History
Eli Lilly announces $3.5 billion manufacturing plant in Pennsylvania's Lehigh Valley to produce obesity drugs including retatrutide, creating 850 high-paying jobs.